You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PR breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Sydney ([68Ga]GA-NeoB)

Recruiting
  • Breast Cancer
  • Sydney, New South Wales, Australia
    St Vincent's Hospital
May 22, 2023

Breast Cancer Trial in Lahore (Aerobic Training, Progressive Resistance Training)

Recruiting
  • Breast Cancer
  • Aerobic Training
  • Progressive Resistance Training
  • Lahore, Punjab, Pakistan
    Chaudhary Muhammad Akram Teaching and research hospital, Jinnah
May 23, 2023

TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Alkaline Glucosodiene Molecules
  • (no location specified)
Jul 14, 2023

Breast Cancer Trial in São Paulo (radiation, procedure, other)

Recruiting
  • Breast Cancer
  • Radiotherapy
  • +2 more
  • São Paulo, SP, Brazil
    ICESP
Aug 5, 2022

Breast Cancer, Brain Metastases Trial in Guangzhou (Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant)

Recruiting
  • Breast Cancer
  • Brain Metastases
  • Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant
  • Guangzhou, Guangdong, China
  • +1 more
Apr 24, 2022

HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)

Active, not recruiting
  • HER2-positive Breast Cancer
  • TQB2440 injection + Trastuzumab + Docetaxel
  • Perjeta + Trastuzumab + Docetaxel
  • Chongqing, Chongqing, China
  • +5 more
Aug 3, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Suspended
  • Anatomic Stage I Breast Cancer AJCC v8
  • +23 more
  • Short-Term Fasting
  • Chemotherapy
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

Metastatic Triple Negative Breast Cancer Trial in Birmingham (Combination of Veliparib + Lapatinib)

Active, not recruiting
  • Metastatic Triple Negative Breast Cancer
  • Combination of Veliparib + Lapatinib
  • Birmingham, Alabama
    University of Alabama at Birmingham
Feb 25, 2022

Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining

Completed
Has Results
  • Breast Cancer
  • San Francisco, California
  • +7 more
Jul 8, 2022

Use of Zoledronic Acid in Breast Cancer Trial in Asyut (Zoledronic Acid 4 MG)

Recruiting
  • Use of Zoledronic Acid in Breast Cancer
  • Zoledronic Acid 4 MG
  • Asyūţ, Asyut, Egypt
    Clinical Oncology Department, Assuit University Hospital
Dec 5, 2021

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)

Recruiting
  • Breast Cancer
  • +3 more
  • Stanford, California
    Stanford University
Feb 16, 2022

Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer Trial (Neratinib, Letrozole (L) or Anastrozole (A),

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Jan 11, 2022

Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Boston (NERATINIB,

Not yet recruiting
  • Stage IV (Metastatic) Breast Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 25, 2021

After Neoadjuvant Chemotherapy for Breast Cancer

Recruiting
  • TN ER-/PR-/HER2- Breast Cancer
  • +3 more
  • Standard Trimodality Breast Imaging
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center
Aug 13, 2021

Invasive Breast Cancer, Triple Negative Breast Cancer, ER-Negative Breast Cancer Trial in Boston, Danvers, Newton (Sacituzumab

Active, not recruiting
  • Invasive Breast Cancer
  • +4 more
  • Boston, Massachusetts
  • +4 more
Oct 25, 2021

Breast Cancer Trial in Brazil (No axillary surgery, SLNB)

Recruiting
  • Breast Cancer
  • No axillary surgery
  • SLNB
  • Fortaleza, CE, Brazil
  • +13 more
Apr 6, 2022

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in New

Suspended
  • Estrogen Receptor-negative Breast Cancer
  • +8 more
  • pegylated liposomal doxorubicin hydrochloride
  • +6 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

Metastatic Breast Cancer Trial in Athens

Recruiting
  • Metastatic Breast Cancer
    • Athens, Greece
      Hellenic Society of Medical Oncology
    Feb 9, 2021

    Anti-Cancer Treatment and Clinical Outcome in Newly Diagnosed

    Active, not recruiting
    • Breast Cancer
    • Buenos Aires, Argentina
    • +30 more
    Aug 2, 2022

    Breast Cancer Trial in Madison (drug, device, other)

    Not yet recruiting
    • Breast Cancer
    • Madison, Wisconsin
      UW Carbone Cancer Center
    Oct 11, 2023

    Breast Cancer Trial in Cambridge (Megestrol Acetate 40 MG, Megestrol Acetate 160 MG, Letrozole)

    Unknown status
    • Breast Cancer
    • Megestrol Acetate 40 MG
    • +2 more
    • Cambridge, Cambridgeshire, United Kingdom
      Cambridge University Hospitals NHS Foundation Trust
    Jan 12, 2021

    Breast Cancer Trial in Boston, Hooksett (Doxorubicin, Cyclophosphamide, Paclitaxel)

    Completed
    Has Results
    • Breast Cancer
    • Boston, Massachusetts
    • +3 more
    Apr 26, 2021

    Breast Cancer. Real Clinical Practice in Russia

    Recruiting
    • Breast Cancer
    • Neoadjuvant Endocrine Therapy
    • Tamoxifen 20mg
    • +4 more
    • Moscow, Russian Federation
      Blokhin's Russian Cancer Research Center
    Apr 5, 2023

    HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer Trial in Belgium, France (Pertuzumab and

    Recruiting
    • HER2-positive Breast Cancer
    • +3 more
    • Pertuzumab and tratuzumab fixed dose combination
    • Trastuzumab emtansine
    • Auchenflower, Australia
    • +84 more
    Jan 16, 2023

    Breast Cancer Trial in Yantai (pyrotinib combined with trastuzumab, dalpiciclib and letrozole)

    Recruiting
    • Breast Cancer
    • pyrotinib combined with trastuzumab, dalpiciclib and letrozole
    • Yantai, Shandong, China
      Yantai Yuhuangding Hospital
    Mar 23, 2023